User profiles for Anna Månberg

Anna Månberg (formerly Häggmark)

Affinity Proteomics, Scilifelab, KTH - Royal Institute of Technology
Verified email at scilifelab.se
Cited by 2333

SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden

AS Rudberg, S Havervall, A Månberg… - Nature …, 2020 - nature.com
SARS-CoV-2 may pose an occupational health risk to healthcare workers. Here, we report
the seroprevalence of SARS-CoV-2 antibodies, self-reported symptoms and occupational …

The human secretome

…, M Malm, AL Volk, P Nilsson, A Månberg… - Science …, 2019 - science.org
The proteins secreted by human cells (collectively referred to as the secretome) are important
not only for the basic understanding of human biology but also for the identification of …

Altered perivascular fibroblast activity precedes ALS disease onset

A Månberg, N Skene, F Sanders, M Trusohamn… - Nature medicine, 2021 - nature.com
Apart from well-defined factors in neuronal cells 1 , only a few reports consider that the
variability of sporadic amyotrophic lateral sclerosis (ALS) progression can depend on less-…

Persisting salivary IgG against SARS-CoV-2 at 9 months after mild COVID-19: a complementary approach to population surveys

…, P De Palma, S Hober, A Månberg… - The Journal of …, 2021 - academic.oup.com
Background Declining humoral immunity in coronavirus disease 2019 (COVID-19) patients
and possible reinfection have raised concern. Mucosal immunity, particularly salivary …

SARS-CoV-2 induces a durable and antigen specific humoral immunity after asymptomatic to mild COVID-19 infection

…, H Tegel, S Mangsbo, M Phillipson, A Månberg… - PloS One, 2022 - journals.plos.org
Current SARS-CoV-2 serological assays generate discrepant results, and the longitudinal
characteristics of antibodies targeting various antigens after asymptomatic to mild COVID-19 …

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

…, N Greilert‐Norin, A Månberg… - Journal of internal …, 2022 - Wiley Online Library
Background Emerging data support detectable immune responses for months after severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and vaccination, but it is …

Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay

…, C Thålin, H Tegel, E Pin, A Månberg… - Clinical & …, 2021 - Wiley Online Library
Objective The COVID‐19 pandemic poses an immense need for accurate, sensitive and
high‐throughput clinical tests, and serological assays are needed for both overarching …

[PDF][PDF] Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis

KA Högelin, N Ruffin, E Pin, A Månberg, S Hober… - Iscience, 2021 - cell.com
B cell depleting therapies (BCDTs) are widely used as immunomodulating agents for
autoimmune diseases such as multiple sclerosis. Their possible impact on development of …

Multiomics profiling of Alzheimer's disease serum for the identification of autoantibody biomarkers

…, MJ Fernandez-Acenero, A Månberg… - Journal of Proteome …, 2021 - ACS Publications
New biomarkers of Alzheimer’s disease (AD) with a diagnostic value in preclinical and
prodromal stages are urgently needed. AD-related serum autoantibodies are potential candidate …

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer's disease

…, B Bosch, R Sanchez‐Valle, A Månberg… - Annals of Clinical …, 2021 - Wiley Online Library
Objective Decreased amyloid beta (Aβ) 42 together with increased tau and phospho‐tau in
cerebrospinal fluid (CSF) is indicative of Alzheimer’s disease (AD). However, the molecular …